Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide( P-ICE) in patients with relapsed or refractory germ cell tumors (GCT)
Kegel, Thomas, Cygon, Franziska, Meinert, Fabian Maximilian, Hammad, Khaled, Steinbach, Frank, Seseke, Florian, Schmoll, Hans-Joachim
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
965 First impressions of patients‘ perspectives of prehabilitation as part of the kore-innovation trial: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer
Marlene Misu Lee, Sehouli, Jalid, Inci-Turan, Melisa Guelhan, Schnura, Eva, Harter, Philipp, Chekerov, Radoslav, Klews, Julia, Roll, Stephanie, Willich, Stefan, Brinkmann, Marlen, Niggemann, Phil, Meinert, Fabian Maximilian, Adak Pirmorady-Sehouli, Reinhold, Thomas, Zimmermann, Manuela, Thorau, Henriette, Runge, Aleksander, Zwanzleitner, Lena, Krull, Andrea, Schneider, Stephanie
Published in International journal of gynecological cancer (01.09.2023)
Published in International journal of gynecological cancer (01.09.2023)
Get full text
Journal Article
“CHARTA”: FOLFOX/Bevacizumab vs. FOLFOXIRI/Bevacizumab in advanced colorectal cancer—Final results, prognostic and potentially predictive factors from the randomized Phase II trial of the AIO
Schmoll, Hans-Joachim, Meinert, Fabian Maximilian, Cygon, Franziska, Garlipp, Benjamin, Junghanss, Christian, Leithäuser, Malte, Vogel, Arndt, Schaefers, Michael, Kaiser, Ulrich, Hoeffkes, Heinz-Gert, Florschütz, Axel, Rüssel, Jörn, Kanzler, Stephan, Edelmann, Thomas, Forstbauer, Helmut, Goehler, Thomas, Hannig, Carla, Hildebrandt, Bert, Steighardt, Jörg, Stein, Alexander
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
CHARTA: FOLFOX+bevacizumab +/- irinotecan in advanced colorectal cancer (CRC)—Final results of the randomized phase II trial of the AIO (KRK 0209)
Schmoll, Hans-Joachim, Garlipp, Benjamin, Junghanss, Christian, Leithaeuser, Malte, Vogel, Arndt, Schaefers, Michael, Kaiser, Ulrich, Hoeffkes, Heinz-Gert, Florschütz, Axel, Rüssel, Jörn, Kanzler, Stephan, Edelmann, Thomas, Forstbauer, Helmut, Goehler, Thomas, Hannig, Carla, Hildebrandt, Bert, Steighardt, Jörg, Meinert, Fabian Maximilian, Cygon, Franziska, Stein, Alexander
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article